LeMaitre Vascular Announces Q2 2020 Financial Results
BURLINGTON, Mass., July 23, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today […]
NexTech AR Announces Public Offering of Units
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR […]
Eight Genesis HealthCare Facilities Receive New American Heart Association Post-Acute Care Heart Failure Center Certification
KENNETT SQUARE, Pa., July 23, 2020 (GLOBE NEWSWIRE) — As part of an effort to reduce avoidable hospital readmissions along […]
CTO Realty Growth Announces Sale of Wawa Ground Lease in Jacksonville, Florida For $7.1 Million
DAYTONA BEACH, Fla., July 23, 2020 (GLOBE NEWSWIRE) — CTO Realty Growth (NYSE American: CTO) (the “Company”) today announced the […]
Glatfelter to Present at the Jefferies Virtual Industrials Conference on August 6th
YORK, Pa., July 23, 2020 (GLOBE NEWSWIRE) — Glatfelter (NYSE:GLT) today announced that Dante C. Parrini, Chairman and Chief Executive […]
Neovasc Announces Partial Prepayment of Convertible Debenture
VANCOUVER and MINNEAPOLIS, July 23, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: […]
Knoll Reports Second Quarter Results
Strong work from home results and channel diversification help to mitigate workplace declinesImplemented $50M of annualized operating expense reductions$164 million […]
Identity, Security and Access Management Solutions Provider BIO-key Completes $24.8 Million Public Offering
WALL, N.J., July 23, 2020 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity, security and […]
Rosetta Stone to Report Second Quarter 2020 Results on August 6, 2020
Arlington, VA, July 23, 2020 (GLOBE NEWSWIRE) — Rosetta Stone Inc. (NYSE:RST), a world leader in technology-based learning solutions, today […]
Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant
Menarini licenses global development and commercialization rights of elacestrant, an oral SERD currently in late stage Phase 3 developmentElacestrant further […]
